Duodenal inflammation: an emerging target for functional dyspepsia?

- Wauters, Lucas, Burns, Grace, Ceulemans, Matthias, Walker, Marjorie M., Vanuytsel, Tim, Keely, Simon, Talley, Nicholas J.

The risk of community-acquired enteric infection in proton pump inhibitor therapy: systematic review and meta-analysis

- Hafiz, Radwan A., Wong, Chia, Paynter, Stuart, David, Michael, Peeters, Geeske

Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference

- Dellon, Evan S., Liacouras, Chris A., Alexander, Jeffrey A., Atkins, Dan, Arva, Nicoleta C., Blanchard, Carine, Bonis, Peter A., Book, Wendy M., Capocelli, Kelley E., Chehade, Mirna, Cheng, Edaire, Collins, Margaret H., Molina-Infante, Javier, Talley, Nicholas J., Walker, Marjorie M., Furuta, Glenn T., Spergel, Jonathan M., Zevit, Noam, Spechler, Stuart J., Attwood, Stephen E., Straumann, Alex, Aceves, Seema S.

Emerging drugs for functional dyspepsia

- Zala, Alkesh V., Walker, Marjorie M., Talley, Nicholas J.

The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor

- Vazquez-Elizondo, G., Ngamruengphong, S., Khrisna, M., DeVault, K. R., Talley, N. J., Achem, S. R.

Management of noncardiac chest pain in women

- Gill, Raghubinder S., Collins, Jo S., Talley, Nicholas J.

A preliminary analysis of the effect Iberogast, Nexium, dual Iberogast + Nexium or dual placebo on symptoms in patients with functional dyspepsia

- Pilichiewicz, A. N., Andrews, J. M., Goess, C., McMahon, J., Fraser, R. J., Beilby, J., Holloway, R. H., Talley, N. J., Holtmann, G.